Therapeutic Effect of Cyclin‐Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis.

MLA

Yamamoto, Akio, et al. “Therapeutic Effect of Cyclin‐Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis.” Arthritis & Rheumatology, vol. 74, no. 5, May 2022, pp. 860–70. EBSCOhost, https://doi.org/10.1002/art.42042.

APA

Yamamoto, A., Saito, T., Hosoya, T., Kawahata, K., Asano, Y., Sato, S., Mizoguchi, F., Yasuda, S., & Kohsaka, H. (2022). Therapeutic Effect of Cyclin‐Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis. Arthritis & Rheumatology, 74(5), 860–870. https://doi.org/10.1002/art.42042

Chicago

Yamamoto, Akio, Tetsuya Saito, Tadashi Hosoya, Kimito Kawahata, Yoshihide Asano, Shinichi Sato, Fumitaka Mizoguchi, Shinsuke Yasuda, and Hitoshi Kohsaka. 2022. “Therapeutic Effect of Cyclin‐Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis.” Arthritis & Rheumatology 74 (5): 860–70. doi:10.1002/art.42042.